Venkatesh Pooladanda, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Limonins | 3 | 2021 | 23 | 2.030 |
Why?
|
| Azadirachta | 1 | 2019 | 2 | 0.660 |
Why?
|
| Anti-Inflammatory Agents | 5 | 2021 | 1793 | 0.590 |
Why?
|
| Liposomes | 2 | 2021 | 777 | 0.590 |
Why?
|
| Selenium | 3 | 2021 | 416 | 0.550 |
Why?
|
| Oligopeptides | 1 | 2021 | 1185 | 0.500 |
Why?
|
| Apoptosis | 12 | 2023 | 9468 | 0.430 |
Why?
|
| Psoriasis | 5 | 2021 | 938 | 0.400 |
Why?
|
| Antineoplastic Agents | 9 | 2023 | 13591 | 0.380 |
Why?
|
| Nanoparticles | 4 | 2021 | 1940 | 0.370 |
Why?
|
| Pneumonia | 1 | 2023 | 2129 | 0.370 |
Why?
|
| Autophagy | 1 | 2018 | 1322 | 0.350 |
Why?
|
| Murraya | 1 | 2019 | 2 | 0.340 |
Why?
|
| Membrane Potential, Mitochondrial | 6 | 2019 | 293 | 0.330 |
Why?
|
| Plant Leaves | 1 | 2019 | 150 | 0.310 |
Why?
|
| Inflammation | 6 | 2023 | 10719 | 0.310 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2019 | 4342 | 0.310 |
Why?
|
| Lipopolysaccharides | 5 | 2023 | 2204 | 0.300 |
Why?
|
| Nanomedicine | 1 | 2019 | 288 | 0.260 |
Why?
|
| Triazoles | 3 | 2020 | 902 | 0.260 |
Why?
|
| Plant Extracts | 1 | 2019 | 489 | 0.250 |
Why?
|
| Keratinocytes | 4 | 2021 | 790 | 0.220 |
Why?
|
| Oxidative Stress | 4 | 2019 | 3100 | 0.220 |
Why?
|
| Reactive Oxygen Species | 5 | 2023 | 2129 | 0.220 |
Why?
|
| Drug Screening Assays, Antitumor | 6 | 2020 | 714 | 0.210 |
Why?
|
| Galectin 1 | 2 | 2020 | 128 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3076 | 0.200 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3196 | 0.200 |
Why?
|
| Galectin 3 | 1 | 2024 | 240 | 0.200 |
Why?
|
| Pancreatitis | 1 | 2019 | 1098 | 0.200 |
Why?
|
| STAT3 Transcription Factor | 3 | 2021 | 869 | 0.190 |
Why?
|
| Lung Neoplasms | 2 | 2023 | 13245 | 0.190 |
Why?
|
| Antioxidants | 1 | 2019 | 1662 | 0.180 |
Why?
|
| Rutin | 1 | 2020 | 16 | 0.180 |
Why?
|
| Suspensions | 1 | 2020 | 66 | 0.180 |
Why?
|
| Cell Cycle Proteins | 2 | 2023 | 3443 | 0.180 |
Why?
|
| Dioxolanes | 1 | 2020 | 23 | 0.170 |
Why?
|
| Ambroxol | 1 | 2019 | 3 | 0.170 |
Why?
|
| Thiazolidines | 1 | 2019 | 68 | 0.170 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2024 | 479 | 0.170 |
Why?
|
| Coumarins | 1 | 2019 | 118 | 0.160 |
Why?
|
| Zoonoses | 1 | 2020 | 178 | 0.160 |
Why?
|
| Benzene | 1 | 2019 | 106 | 0.160 |
Why?
|
| Tubulin Modulators | 1 | 2019 | 106 | 0.160 |
Why?
|
| Genital Neoplasms, Female | 1 | 2024 | 533 | 0.160 |
Why?
|
| Transcription Factor RelA | 1 | 2019 | 250 | 0.160 |
Why?
|
| Blood Proteins | 1 | 2024 | 1173 | 0.160 |
Why?
|
| Endotoxins | 1 | 2021 | 521 | 0.150 |
Why?
|
| Histone Deacetylase 2 | 1 | 2018 | 72 | 0.150 |
Why?
|
| Drug Design | 2 | 2020 | 1049 | 0.150 |
Why?
|
| NFATC Transcription Factors | 1 | 2019 | 381 | 0.150 |
Why?
|
| Cell Line, Tumor | 8 | 2024 | 16886 | 0.150 |
Why?
|
| Azepines | 1 | 2019 | 329 | 0.140 |
Why?
|
| Ketones | 1 | 2018 | 183 | 0.140 |
Why?
|
| Skin | 3 | 2020 | 4464 | 0.140 |
Why?
|
| Nuclear Proteins | 2 | 2023 | 5787 | 0.140 |
Why?
|
| Benzoquinones | 1 | 2017 | 198 | 0.140 |
Why?
|
| Morpholines | 1 | 2019 | 580 | 0.130 |
Why?
|
| Tubulin | 1 | 2019 | 692 | 0.130 |
Why?
|
| Epigenesis, Genetic | 2 | 2020 | 3754 | 0.130 |
Why?
|
| Acetylation | 1 | 2018 | 1060 | 0.130 |
Why?
|
| Benzimidazoles | 1 | 2020 | 855 | 0.120 |
Why?
|
| Uterine Neoplasms | 1 | 2024 | 1439 | 0.120 |
Why?
|
| Indoles | 2 | 2019 | 1828 | 0.120 |
Why?
|
| Structure-Activity Relationship | 4 | 2020 | 3069 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 5 | 2021 | 6209 | 0.110 |
Why?
|
| Molecular Conformation | 3 | 2019 | 543 | 0.110 |
Why?
|
| Lung | 2 | 2023 | 9985 | 0.110 |
Why?
|
| Translocation, Genetic | 1 | 2019 | 1387 | 0.110 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2023 | 2053 | 0.110 |
Why?
|
| Animals | 12 | 2024 | 167777 | 0.110 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 1074 | 0.110 |
Why?
|
| Mice | 9 | 2024 | 81107 | 0.100 |
Why?
|
| Cell Proliferation | 7 | 2024 | 10417 | 0.100 |
Why?
|
| Cell Line | 3 | 2021 | 15594 | 0.100 |
Why?
|
| Transcription Factors | 2 | 2023 | 12096 | 0.100 |
Why?
|
| Niclosamide | 2 | 2023 | 9 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 1404 | 0.100 |
Why?
|
| Histones | 2 | 2020 | 2577 | 0.090 |
Why?
|
| Molecular Structure | 3 | 2020 | 1865 | 0.090 |
Why?
|
| Skin Diseases | 1 | 2019 | 1088 | 0.090 |
Why?
|
| Osteoporosis | 1 | 2020 | 1599 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2019 | 2472 | 0.090 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 3840 | 0.080 |
Why?
|
| Drug Delivery Systems | 1 | 2021 | 2211 | 0.080 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 1895 | 0.080 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2018 | 2057 | 0.080 |
Why?
|
| Cell Survival | 1 | 2018 | 5781 | 0.080 |
Why?
|
| Humans | 21 | 2024 | 758381 | 0.080 |
Why?
|
| Ovarian Neoplasms | 1 | 2024 | 4876 | 0.070 |
Why?
|
| DNA | 1 | 2019 | 7199 | 0.060 |
Why?
|
| Melanoma | 1 | 2023 | 5691 | 0.060 |
Why?
|
| Macrophages | 1 | 2019 | 5737 | 0.060 |
Why?
|
| Crystallography, X-Ray | 2 | 2018 | 1974 | 0.060 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 1 | 2024 | 136 | 0.060 |
Why?
|
| Protein Binding | 3 | 2020 | 9312 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 18125 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 22006 | 0.050 |
Why?
|
| CA-125 Antigen | 1 | 2024 | 279 | 0.050 |
Why?
|
| Galectins | 1 | 2024 | 282 | 0.050 |
Why?
|
| Signal Transduction | 3 | 2019 | 23341 | 0.050 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2020 | 98 | 0.040 |
Why?
|
| Keratin-17 | 1 | 2020 | 26 | 0.040 |
Why?
|
| Excipients | 1 | 2020 | 97 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 8611 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2023 | 728 | 0.040 |
Why?
|
| GTP Phosphohydrolases | 1 | 2023 | 517 | 0.040 |
Why?
|
| X-Ray Diffraction | 1 | 2020 | 420 | 0.040 |
Why?
|
| Biological Availability | 1 | 2020 | 390 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2021 | 8297 | 0.040 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2020 | 275 | 0.040 |
Why?
|
| Hydrogen Bonding | 1 | 2019 | 290 | 0.040 |
Why?
|
| Intestinal Absorption | 1 | 2020 | 400 | 0.040 |
Why?
|
| Drug Compounding | 1 | 2020 | 245 | 0.040 |
Why?
|
| Static Electricity | 1 | 2019 | 261 | 0.040 |
Why?
|
| Solubility | 1 | 2020 | 1087 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2020 | 940 | 0.040 |
Why?
|
| Permeability | 1 | 2020 | 718 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2023 | 730 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 398 | 0.040 |
Why?
|
| Catalysis | 1 | 2019 | 772 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2020 | 10747 | 0.040 |
Why?
|
| Drug Repositioning | 1 | 2019 | 231 | 0.040 |
Why?
|
| Fluorine Radioisotopes | 1 | 2020 | 413 | 0.040 |
Why?
|
| Oxazoles | 1 | 2018 | 199 | 0.040 |
Why?
|
| Skin Absorption | 1 | 2017 | 94 | 0.040 |
Why?
|
| Male | 5 | 2021 | 358742 | 0.040 |
Why?
|
| Copper | 1 | 2019 | 366 | 0.040 |
Why?
|
| Epidermis | 1 | 2020 | 528 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2024 | 3801 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2020 | 1844 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2019 | 895 | 0.030 |
Why?
|
| Particle Size | 1 | 2020 | 1641 | 0.030 |
Why?
|
| Hyperplasia | 1 | 2019 | 1154 | 0.030 |
Why?
|
| Chemokines | 1 | 2020 | 961 | 0.030 |
Why?
|
| Administration, Topical | 1 | 2017 | 697 | 0.030 |
Why?
|
| Histone Deacetylases | 1 | 2020 | 719 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2021 | 2222 | 0.030 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2020 | 772 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2023 | 2907 | 0.030 |
Why?
|
| Pyrroles | 1 | 2019 | 1130 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2020 | 6127 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2020 | 3993 | 0.020 |
Why?
|
| Cell Movement | 1 | 2024 | 5201 | 0.020 |
Why?
|
| Interleukin-17 | 1 | 2017 | 908 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2018 | 2646 | 0.020 |
Why?
|
| Binding Sites | 1 | 2019 | 6036 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 21017 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2017 | 1888 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 1878 | 0.020 |
Why?
|
| Mitochondria | 1 | 2023 | 3584 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2017 | 3208 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2023 | 7843 | 0.020 |
Why?
|
| Cytokines | 1 | 2019 | 7338 | 0.010 |
Why?
|
| Rats | 1 | 2020 | 23681 | 0.010 |
Why?
|
| Models, Biological | 1 | 2020 | 9461 | 0.010 |
Why?
|
| Prognosis | 1 | 2024 | 29558 | 0.010 |
Why?
|
| Female | 3 | 2024 | 390316 | 0.010 |
Why?
|
| Mutation | 1 | 2023 | 29915 | 0.010 |
Why?
|